BioTrackTHC Deploys Puerto Rico Traceability System, Expands Presence
April 24th, 2018
News, Top News
FORT LAUDERDALE, Fla., April 24, 2018 /PRNewswire/ — The Commonwealth of Puerto Rico in coordination with the Department of Health’s seed-to-sale traceability provider, BioTrackTHC, has officially deployed its government seed-to-sale Traceability System to oversee the island’s medical cannabis industry. The system will enable the government to track and regulate the medical cannabis supply chain, product safety, and sales.
Puerto Rico originally announced BioTrackTHC as the winner apparent of the contract in late 2016. However, there was a series of protests from competing vendors that were ultimately dismissed. The contract was then officially executed by the Puerto Rico Department of Health and BioTrackTHC in February of 2018. The Traceability System is being deployed in phases, with the first phase going live today, Tuesday, April 24, 2018.
“Our goal is to provide safe access to medical cannabis for all of our patients in Puerto Rico. The Traceability System empowers us to provide them with access in a way that is both transparent and responsible,” said Antonio Quilichini, Executive Director of the Regulatory Board for Medical Cannabis. “Additionally, it will enable the medical cannabis board to properly track the island’s supply chain in real time, with complete visibility and accountability.”
Because of the unique nature of Puerto Rico’s medical cannabis program, as well as the fact that a large number of licensees and their employees are Spanish-speaking, BioTrackTHC recently opened an office on the island and currently employs two staff members locally who are exclusively focused on supporting the Department of Health, the Puerto Rico licensees, the company’s Spanish-speaking customers, and the Puerto Rico Traceability program at-large.
“It is an honor to be in a position to help launch the island’s medical cannabis program and assist the licensees in getting up and running on the Traceability System,” said James Tolentino, Director of Puerto Rico Operations for BioTrackTHC.
There are currently over 60 licensed cannabis businesses who are approved by the State to distribute medical cannabis to approved patients in Puerto Rico. The launch of the Traceability System provides these patients with an accessible program as well as safe, lab-tested medical cannabis.
As previously announced in March of this year, BioTrackTHC and Helix TCS Inc. (OTCQB: HLIX) have signed a definitive merger agreement. The signing of this contract helps to further establish BioTrackTHC as a leader in government traceability as they now hold nine (9) executed seed-to-sale contracts.
Bio-Tech Medical Software, Inc., through its BioTrackTHC division, develops and provides effective, cutting-edge technology solutions for the emerging medical and recreational cannabis industry. Visit www.biotrack.com for more information, email [email protected] or call 1-800-797-4711 to order software. Follow us on Facebook, Twitter and LinkedIn for important updates and relevant industry news. BioTrackTHC currently holds 9 government contracts and operates in over 2000 locations across 28 states, D.C., and 4 countries. Bio-Tech Medical Software, Inc. is a privately-held company based in Fort Lauderdale, Florida.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.